27.04.2018 13:00:00

Aralez To Announce First Quarter 2018 Results On May 8, 2018

-Executive Management to Host Conference Call on May 8, 2018 at 8:00 a.m. ET-

MISSISSAUGA, Ontario, April 27, 2018 /CNW/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) today announced that it will report its first quarter 2018 financial results on Tuesday, May 8, 2018, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:00 a.m. ET on such date to discuss the financial results and recent highlights.

Audio Webcast/ Conference Call Details
Date: Tuesday, May 8, 2018
Time: 8:00 a.m. ET
Dial-in (U.S.): 877-407-8037
Dial-in (International): 201-689-8037

A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at www.aralez.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for two weeks.

About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular and other specialty areas. Aralez's Global Headquarters is in Mississauga, Ontario, Canada, the U.S. Headquarters is in Princeton, New Jersey, USA and the Irish Headquarters is in Dublin, Ireland. More information about Aralez can be found at www.aralez.com.

Aralez Pharmaceuticals US Inc. Contact

Nichol L. Ochsner

Executive Director, Investor Relations & Corporate Communications

732-754-2545

nochsner@aralez.com

 

Cision View original content:http://www.prnewswire.com/news-releases/aralez-to-announce-first-quarter-2018-results-on-may-8-2018-300637338.html

SOURCE Aralez Pharmaceuticals Inc.

Nachrichten zu Aralez Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Aralez Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Aralez Pharmaceuticals Inc 0,43 10,26% Aralez Pharmaceuticals Inc